Prothena Long Term Debt from 2010 to 2025
| PRTA Stock | USD 10.33 0.46 4.66% |
Long Term Debt | First Reported 2013-03-31 | Previous Quarter 32.3 M | Current Value 21.7 M | Quarterly Volatility 18.1 M |
Check Prothena Plc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Prothena Plc's main balance sheet or income statement drivers, such as Depreciation And Amortization of 848.4 K, Interest Expense of 8.1 M or Selling General Administrative of 37.2 M, as well as many indicators such as Price To Sales Ratio of 5.23, Dividend Yield of 0.0 or PTB Ratio of 1.45. Prothena financial statements analysis is a perfect complement when working with Prothena Plc Valuation or Volatility modules.
Prothena | Long Term Debt | Build AI portfolio with Prothena Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| PRNEX | T Rowe Price | |
| RPBAX | T Rowe Price | |
| PRDGX | T Rowe Price |
Check out the analysis of Prothena Plc Correlation against competitors. For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prothena Plc. If investors know Prothena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prothena Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.44) | Revenue Per Share | Quarterly Revenue Growth 1.49 | Return On Assets | Return On Equity |
The market value of Prothena plc is measured differently than its book value, which is the value of Prothena that is recorded on the company's balance sheet. Investors also form their own opinion of Prothena Plc's value that differs from its market value or its book value, called intrinsic value, which is Prothena Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prothena Plc's market value can be influenced by many factors that don't directly affect Prothena Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prothena Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prothena Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prothena Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.